Everything below concerns lyophilisation. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Quality assessment of research-grade peptide rests mainly on reversed-phase high-performance liquid chromatography for purity and on mass spectrometry for identity confirmation. A single main peak above a stated threshold, commonly ninety-eight percent by peak area, is the usual release criterion applied by suppliers. Independent analyses commissioned by laboratories and consumer organisations have repeatedly reported discrepancies between label claims and measured content, including truncated sequences, residual trifluoroacetate, and lower-than-declared peptide mass. Those findings do not establish that every supplier is unreliable, but they indicate that purity figures printed on a vial are claims requiring verification rather than settled facts.
Regulatory treatment varies by jurisdiction and has changed over time. In several countries the peptide is handled as an unapproved prescription medicine, and import or sale for human use is restricted, while elsewhere it falls under poisons or controlled-substance schedules. Enforcement activity against online vendors has been reported in Australia, New Zealand, the United Kingdom and the United States. Scholarly writing discusses melanotan-2 chiefly as an experimental tool and as a case study in unregulated peptide supply, and its precise legal position in any given country should be checked against current national schedules.
Lyophilised melanotan-2 is comparatively robust when kept dry, cold and dark, and a desiccated powder stored at minus twenty degrees Celsius or below is generally expected to retain its chemical integrity for extended periods. In solution the peptide is far less stable, with degradation proceeding through oxidation of tryptophan and histidine residues, hydrolysis adjacent to the lactam bridge, and aggregation at higher concentrations. Repeated freeze-thaw cycling accelerates loss of the parent peak. Working aliquots are therefore prepared once, held cold, and used without letting the stock return to ambient temperature.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic cyclic heptapeptide | Analog of alpha-MSH with an internal lactam bridge |
| Molecular weight | Approximately 1024 daltons | Free base value; salt forms differ |
| Appearance | White to off-white powder | Usually supplied as a lyophilized solid |
| Solubility | Freely soluble in water | Poorly soluble in nonpolar solvents |
| Typical storage | −20 °C, dry, protected from light | Repeated freeze-thaw cycles degrade peptides |
Published pharmacokinetic information is limited and comes mainly from small studies rather than registrational trials. Plasma half-life is usually described as short, on the order of tens of minutes, followed by rapid tissue distribution and clearance of the intact peptide. Metabolites and low concentrations of parent compound have been reported in urine, a detail relevant to anti-doping and forensic testing. Whether repeated exposure changes receptor sensitivity or clearance over time remains an open question. Values differ noticeably between analytical assays, so published numbers should be read as approximate rather than definitive.
Melanotan II is a synthetic cyclic heptapeptide with the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, corresponding to a molecular formula of C50H69N15O9 and a monoisotopic mass near 1024 daltons. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, a peptide hormone produced by cleavage of proopiomelanocortin. A lactam bridge between the aspartate and lysine side chains closes the ring, and the C-terminal amide removes a free carboxyl group. Both modifications increase resistance to enzymatic degradation compared with the linear parent hormone. Four substitutions distinguish it from afamelanotide, the linear analogue studied under the name melanotan I.
Regulatory status varies by jurisdiction, and the substance is frequently described as unapproved for therapeutic use. Some authorities classify it alongside prescription-only medicines or controlled categories, while others address it through general consumer protection rules. Analytical surveys have reported mismatches between label claims and measured content in products sold online, although the scope of such testing is limited. Whether these discrepancies are widespread remains an open question. Discussion in the literature therefore tends to combine chemistry, supply-chain observation and policy analysis.
The material is commonly handled as a lyophilized powder in sealed vials. The solid dissolves readily in water and in polar organic solvents, producing a clear solution after reconstitution. Light, heat and repeated freeze-thaw cycles are the concerns most often raised in handling guidance, because peptide bonds and the constrained ring can degrade. Working solutions are generally prepared fresh, and material left in solution is treated as less stable than the dry form. These properties shape how laboratories store and aliquot reference material.
Regulatory treatment varies between countries. Several national medicines agencies have classified the peptide as unapproved, and customs authorities in some jurisdictions seize shipments on that basis. A few jurisdictions channel supply through prescription-only frameworks that do not list the substance by name. Because the material circulates mainly through online vendors, composition and purity are rarely verified before sale. Surveys of unapproved peptide products have reported labels that did not match measured content in a substantial fraction of samples.
Melanotan II is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its structure substitutes a lactam bridge between side chains to increase stability relative to the native hormone. The compound is also known by the shorthand MT-II and by several non-proprietary synonyms used in research catalogues. It is not an approved therapeutic product in any major jurisdiction; material sold under this name is typically offered as a laboratory reagent rather than as a medicine.
Activity is attributed to agonism at melanocortin receptors, particularly MC1R and MC4R. Activation of MC1R on melanocytes increases melanin synthesis, which underlies the reported tanning effect. MC4R engagement in the central nervous system is linked to appetite suppression and to effects on sexual arousal reported in early clinical studies. Those studies were small and were not designed to establish efficacy or long-term safety. Receptor selectivity among the melanocortin subtypes is not absolute, which complicates attribution of any effect to a single pathway.
Teleostei (; from Ancient Greek τέλειος (téleios) 'complete' and ὀστέον (ostéon) 'bone'), members of which are known as teleosts (), is, by far, the largest group of ray-finned fishes (class Actinopterygii), with 96% of all extant species of fish. The Teleostei, which is variously considered a division or an infraclass in different taxonomic systems, include over 26,000 species that are arranged in about 40 orders and 448 families. Teleosts range from giant oarfish measuring 7.6 m (25 ft) or more, and ocean sunfish weighing over 2 t (2.0 long tons; 2.2 short tons), to the minute male anglerfish Photocorynus spiniceps, just 6.2 mm (0.24 in) long. Including not only torpedo-shaped fish built for speed, teleosts can be flattened vertically or horizontally, be elongated cylinders or take specialised shapes as in anglerfish and seahorses. The difference between teleosts and other bony fish lies mainly in their jaw bones; teleosts have a movable premaxilla and corresponding modifications in the jaw musculature which make it possible for them to protrude their jaws outwards from the mouth. This is of great advantage, enabling them to grab prey and draw it into the mouth. In more derived teleosts, the enlarged premaxilla is the main tooth-bearing bone, and the maxilla, which is attached to the lower jaw, acts as a lever, pushing and pulling the premaxilla as the mouth is opened and closed. Other bones further back in the mouth serve to grind and swallow food. Another difference is that the upper and lower lobes of the tail (caudal) fin are about equal in size.
Recombinant DNA fact sheet (from University of New Hampshire) Plasmids in Yeasts (Fact sheet from San Diego State University) Recombinant DNA research at UCSF and commercial application at Genentech Edited transcript of 1994 interview with Herbert W. Boyer, Living history project. Oral history. Recombinant Protein Purification Principles and Methods Handbook Archived 2008-12-05 at the Wayback Machine Massachusetts Institute of Technology, Oral History Program, Oral History Collection on the Recombinant DNA Controversy, MC-0100. Massachusetts Institute of Technology, Department of Distinctive Collections, Cambridge, Massachusetts
== Catalyzed reaction == Tyrosinase carries out the oxidation of phenols such as tyrosine and dopamine using molecular oxygen (O2). In the presence of catechol, benzoquinone is formed (see reaction below). Hydrogens removed from catechol combine with oxygen to form water. The substrate specificity becomes dramatically restricted in mammalian tyrosinase which uses only L-form of tyrosine or DOPA as substrates, and has restricted requirement for L-DOPA as cofactor.
=== Second generation === In 1976, 24-year-old Rich Snyder became the company president after his father's death. Along with his brother Guy, Rich had begun working in his father's In-N-Outs at an early age. Over the next 20 years, the chain experienced a period of rapid growth under Rich's leadership, expanding to 93 restaurants. In June 1988, In-N-Out opened its 50th location, in Thousand Palms, California. The first location outside of the Los Angeles metropolitan area opened in San Diego County in 1990, the 57th location in the chain. In 1992, In-N-Out opened its first non-Southern California restaurant, in Las Vegas, Nevada. Its first Northern California location opened the following year in Modesto. Expansion then spread to Northern California, including the San Francisco Bay Area, while additional Las Vegas-area restaurants were added. After opening the 93rd In-N-Out store in Fresno, California, on December 15, 1993, Rich Snyder and four other passengers died in a plane crash on approach to John Wayne Airport in Orange County, California. Upon Rich Snyder's death, Guy Snyder assumed the presidency in January 1994 and continued the company's aggressive expansion until he died from an overdose of painkillers in 1999. Under his leadership, In-N-Out's 100th location was opened in Gilroy, California, on November 10, 1994. He was president for nearly six years, expanding In-N-Out from 93 to 140 locations. His mother Esther subsequently took over the presidency.
Sources: en.wikipedia.org
According to the Nigerian constitution, all minerals, gas, and oil the country possesses are legally the property of the Nigerian Federal Government. The revenue gained by the NNPC accounts for 76% of federal government revenue and 40% of the entire country's GDP. As of 2000, oil and gas exports account for 98% of Nigerian export earnings.
Counter-Strike (also known as Half-Life: Counter-Strike or Counter-Strike 1.6) is a 2000 tactical first-person shooter game developed by Valve Corporation and published by Sierra Studios. It is the first installment in the Counter-Strike series. The game pits two teams—the Counter-Terrorists and Terrorists—against each other in objective-based game modes. The most common objectives are bomb defusal and hostage rescue, each played on designated maps. Players begin with a knife and pistol, and they can purchase more advanced weapons and equipment with money earned through eliminating enemies or accomplishing goals. Once eliminated, players do not respawn until the end of the round. Minh Le and Jess Cliffe planned a game based on counter-terrorism in 1998 with development beginning the following year when the first few beta versions were released. Their initial version of the game started as a modification for Half-Life and gained significant popularity and interest, which attracted Valve. Valve went on to acquire the game's intellectual property and announced a partnership with Le and Cliffe. After finishing development, Counter-Strike was released by Valve for Microsoft Windows in November 2000. Several remakes and ports were released on Xbox, as well as OS X and Linux. Since its release, Counter-Strike received positive reviews from critics who praised the gameplay and its emphasis on teamwork and strategy. It has been called one of the most influential first-person shooters and noted for its realistic and tactical approach to counter-terrorism.
As f decreases progressively during condensation, the remaining vapor becomes more and more depleted of the heavy isotopes, and the depletion becomes larger as f approaches zero. Rayleigh distillation can explain some first-order spatial patterns observed in the isotopic composition of precipitation across the globe, including isotopic depletion from the tropics to the poles, isotopic depletion from coastal to inland regions, and isotopic depletion with elevation over a mountain range,[1] all of which are associated with progressive moisture loss during transport. The Rayleigh distillation model can also be used to explain the strong correlation between δD and δ18O in global precipitation, expressed as the global meteoric water line (GMWL): δD = 8δ18O+10 (later updated to δD = 8.17±0.07 δ18O+11.27±0.65) The slope of the GMWL reflects the relative magnitude of hydrogen and oxygen isotope fractionation during condensation. The intercept of GMWL is non-zero (called deuterium-excess, or d-excess), which means ocean water does fall on GMWL. This is associated with the KIE during evaporation when water vapor diffuses from the saturated boundary layer to the unsaturated transition zone, and cannot be explained by the Rayleigh model. Nevertheless, the robust pattern in GMWL strongly suggests a single dominant moisture source to the global atmosphere, which is the tropical West Pacific. It should also be pointed out that a local meteoric water line can have a different slope and intercept from the GMWL, due to differences in humidity and evaporation intensity at different places.
The socialists proposed the full integration of Spain into Europe, but when they took office the negotiations for the accession to the European Economic Community (EEC) were still blocked because of the "pause" in the enlargement imposed by the French president Giscard d'Estaing. However, the triumph in the presidential elections of the socialist François Mitterrand allowed rapid progress in the negotiations and so on June 12, 1985, the EEC accession treaty was signed and on January 1, 1986, Spain joined the EEC together with Portugal.
The lowering of the blood cholesterol level can reduce the risk of coronary heart disease." β-glucan lowers cholesterol in part by increasing the viscosity of digesta in the small intestine, although cholesterol reduction is greater in those with higher total cholesterol and LDL cholesterol in their blood. Additionally, studies suggest that it increases the activity of CYP7A1, a key enzyme in the synthesis of bile acids, thus increasing the excretion of cholesterol, and that it may have additional anti-atherogenic mechanisms. The degree of cholesterol reduction depends upon the particular strain of β-glucan in a range between a molecular weights of 26.8 and 3000 kD. Although more viscous β-glucans result in a more viscous solution of intestinal digesta, and thus more cholesterol uptake, after a certain molecular weight, β-glucans become less soluble and thus contribute less to solution viscosity. The intake of β-glucan in liquid form generally results in greater solubilization and oat β-glucan is more effective at lowering cholesterol in juices than in hard foods like bread and cookies. Despite the recognized impact of viscosity on serum cholesterol levels, no current data exists comparing internal solution viscosity and serum cholesterol. Intake of oat β-glucan at daily amounts of at least 3 grams lowers total and low-density lipoprotein cholesterol levels by 5–10% in people with normal or elevated blood cholesterol levels.
Sources: en.wikipedia.org
== See also == Scabs (disambiguation) Channeled Scablands, an eroded landscape formed by Missoula Floods in the U.S. state of Washington Scabies, a skin disease caused by the mite Sarcoptes scabiei U.S. Wheat and Barley Scab Initiative, a joint government and academic program to develop control measures to minimize the threat of Fusarium head blight (scab) in the United States
Junior doctors in England vote to strike in their ongoing dispute for a 26% pay rise, and will stage a 72-hour walkout. The BMA maintains junior doctors' pay has been cut by 26% since 2008 after inflation is considered. 21 February The UK Government announces that it had a budget surplus in January, with £5bn more in revenue than predicted. A planned 48-hour strike by nurses in England is called off to allow the Royal College of Nursing and Department of Health and Social Care to enter into renewed negotiations. The broadcasting regulator Ofcom writes to both ITV News and Sky News to ask them for an explanation of their actions following complaints made by the family of Nicola Bulley. Her family had been contacted by both outlets despite asking for privacy. Asda and Morrisons announce they are limiting the sale of some fruit and vegetable products, such as tomatoes, peppers and cucumbers, because of a shortage caused by severe weather in Spain and North Africa which has affected harvests. The UK Government recommends a 3.5% pay rise for public sector workers in England, below the rate of inflation. 22 February Shamima Begum loses her legal challenge to overturn the decision to remove her UK citizenship. Tesco and Aldi Süd follow Asda and Morrisons by introducing limits on the purchase of some fruit and vegetables. Lancashire Police and Crime Commissioner Andrew Snowden commissions the College of Policing to review the force's investigation into the disappearance of Nicola Bulley, including the release of information about her private life.
== In other animals == Demyelinating diseases/disorders have been found worldwide in various animals. Some of these animals include mice, pigs, cattle, hamsters, rats, sheep, Siamese kittens, and a number of dog breeds (including Chow Chow, Springer Spaniel, Dalmatian, Samoyed, Golden Retriever, Lurcher, Bernese Mountain Dog, Vizsla, Weimaraner, Australian Silky Terrier, and mixed breeds). Ziggy Star, a female northern fur seal, was treated at the Marine Mammal Center beginning in March 2014 and was noted as the first reported case of a demyelinating disease in a marine mammal. She was later transported to Mystic Aquarium & Institute for Exploration for lifelong care as an ambassador to the public. In 2017, she was the first seal treated for hydrocephalus.
=== Cancer === Preliminary studies suggest that FFAR2 may be involved in some types of cancer. 1) One study found that FFAR2 levels were elevated in human stomach and colorectal cancers although another study reported that FFAR2 levels were markedly deceased in human colorectal cancer. These results suggest that FFAR2 may promote the development and/or progression of human stomach cancer but its impact on human colorectal cancer requires further study. 2) In a dextran sulfate sodium-induced model of inflammation-associated colon cancer, FFAR2 knockdown mice developed larger and more tumors than control mice. This study suggests that FFAR2 inhibits the development and/or progression of inflammation-associated colon carcinoma in mice; its role in human inflammation-associated colorectal cancer (e.g., colorectal cancer developing in ulcerative colitis) has not been clarified. 3) Compared to their normal lung tissues, the lung cancer tissues of 42 patients had lower levels of FFAR2 but not FFAR1, FFAR3, or FFAR4. 4) Butyric acid inhibited the proliferation of and triggered apoptosis in cultured human A549 lung cancer cells; further studies in A549 as well as H1299 human lung cancer cells found that propionic acid inhibited their stimulated migration, invasiveness, and colony growth in cell culture assays but did not do so in FFAR2 gene knockout A549 or H1299 cells. These results suggest that FFAR2 may inhibit the development and/or progression of human lung cancer.
The phase 2 study of LGD-4033 for muscle wasting was finally initiated in November 2016 and was completed with results reported in 2017 and 2018. As of March 2023, LGD-4033 (VK5211) continues to be under development by Viking Therapeutics and continues to be in phase 2 clinical trials for treatment of muscle atrophy and hip fracture.
Sources: en.wikipedia.org
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.
Melanotan-1, also called afamelanotide, is a shorter linear analog with a different amino acid sequence and no lactam ring. It has been evaluated in formal clinical programs, while melanotan-2 has not. The two are distinct molecules and are not interchangeable.
No. Bremelanotide is a related but distinct cyclic peptide that reached approved status for one specific clinical indication. Melanotan-2 is a separate molecule with its own sequence and properties. Shared ancestry in the melanocortin family does not make them the same substance.
Solutions are best kept cold, protected from light, and buffered to a pH that limits hydrolysis. Dividing a stock into single-use aliquots avoids repeated freeze-thaw cycles, which measurably reduce the intact parent peak over time.